ESC 365 - The selective Rho Kinase 2 inhibitor Chroman-1, is a potent vasodilator but does not compromise left ventricular function in-vivo

ESC Professional Premium Access

The selective Rho Kinase 2 inhibitor Chroman-1, is a potent vasodilator but does not compromise left ventricular function in-vivo

Session: Vascular dysfunction

Topic: Ischaemia, Infarction, Cardioprotection

Speaker: Doctor L. Pearce (London, GB)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Lucie E Pearce

University College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

A better understanding of coronary artery disease molecular biology through an intermediate phenotype

Speaker: Doctor D. Sa (Funchal, PT)

South Asian adults with ASCVD exhibit a reduction in circulating vascular regenerative cell content compared to White European adults: a sub-analysis of the ORIGINS-RCE CardioLink-13 study.

Speaker: Ms A. Krishnaraj (Toronto, CA)

Identification of the low wall shear stress area in the middle and distal coronary artery: a dynamic angiography and deep learning analysis

Speaker: Doctor L. Vu (Long An, VN)

Endothelial junctional protein associated with coronary artery disease (JCAD) as a potential therapeutic target for acute ischemic stroke

Speaker: Doctor S. Ministrini (Zurich, CH)

Therapeutic modulation of epigenetic readers rescues obesity-induced vascular dysfunction: role of endothelium and perivascular adipose tissue

Speaker: Doctor A. Mengozzi (Pisa, IT)

Access the full session

Vascular dysfunction

Speakers: Doctor L. Pearce, Doctor D. Sa, Ms A. Krishnaraj, Doctor L. Vu, Doctor S. Ministrini...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources